Research

Macro partitioning

Specific Carbohydrate Diet (SCD) shows potential for improving disease activity and inflammatory markers in pediatric IBD, with some self-reported benefits in adults, but large-scale adult trials are needed.

The Specific Carbohydrate Diet (SCD) shows promise, particularly in children with IBD, where it has been linked to reduced disease activity and inflammation. In adults, self-reported outcomes are positive, but robust clinical trials are still needed. It may be worth discussing with your gastroenterologist, especially if other treatments are insufficient.

ModerateQualifiesMEDIUM confidence
SCD appears to have a significantly positive impact on Pediatric Crohn’s Disease Activity Index (PCDAI) and Pediatric Ulcerative Colitis Activity Index (PUCAI) scores... resulted in a significant improvement in CRP... and calprotectin... Nearly 70% of patients self-reported no symptoms while on an SCD... 42% of patients reported achieving remission at both 6 and 12 months while adhering to the diet
Yan Jiang et al. · Nutrients · 2021

Why this rating

Strong pediatric data, but adult data relies on case series and surveys with potential bias.

Source

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases

Yan Jiang et al. · Nutrients · 2021

DOI 10.3390/nu13030890

narrative_reviewCited 89×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →